Next Article in Journal
Emerging Non-Thermal Technologies for the Extraction of Grape Anthocyanins
Next Article in Special Issue
Murine Neonatal Oxidant Lung Injury: NRF2-Dependent Predisposition to Adulthood Respiratory Viral Infection and Protection by Maternal Antioxidant
Previous Article in Journal
An In Vitro and In Silico Study of the Enhanced Antiproliferative and Pro-Oxidant Potential of Olea europaea L. cv. Arbosana Leaf Extract via Elastic Nanovesicles (Spanlastics)
Previous Article in Special Issue
Bioactive Compounds in Oxidative Stress-Mediated Diseases: Targeting the NRF2/ARE Signaling Pathway and Epigenetic Regulation
 
 
Review

The Role of NRF2 in Mycobacterial Infection

Department of Respiratory Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Ibaraki, Japan
*
Author to whom correspondence should be addressed.
These authors contributed equally: Masashi Matsuyama and Mizu Nonaka.
Academic Editors: Wael El-Rifai, Hye-Youn Cho and Steven R. Kleeberger
Antioxidants 2021, 10(12), 1861; https://doi.org/10.3390/antiox10121861
Received: 3 September 2021 / Revised: 11 November 2021 / Accepted: 22 November 2021 / Published: 23 November 2021
(This article belongs to the Special Issue NRF2 in Health and Diseases)
The incidence of pulmonary nontuberculous mycobacterial (NTM) infection is increasing worldwide, and its clinical outcomes with current chemotherapies are unsatisfactory. The incidence of tuberculosis (TB) is still high in Africa, and the existence of drug-resistant tuberculosis is also an important issue for treatment. To discover and develop new efficacious anti-mycobacterial treatments, it is important to understand the host-defense mechanisms against mycobacterial infection. Nuclear erythroid 2 p45-related factor-2 (NRF2) is known to be a major regulator of various antioxidant response element (ARE)-driven cytoprotective gene expressions, and its protective role has been demonstrated in infections. However, there are not many papers or reviews regarding the role of NRF2 in mycobacterial infectious disease. Therefore, this review focuses on the role of NRF2 in the pathogenesis of Mycobacterium tuberculosis and Mycobacterium avium infection. View Full-Text
Keywords: ROS; NRF2; ARE; TB; NTM; IFN-γ; HO-1; NRAMP1 ROS; NRF2; ARE; TB; NTM; IFN-γ; HO-1; NRAMP1
Show Figures

Figure 1

MDPI and ACS Style

Matsuyama, M.; Nonaka, M.; Nakajima, M.; Morishima, Y.; Ishii, Y.; Hizawa, N. The Role of NRF2 in Mycobacterial Infection. Antioxidants 2021, 10, 1861. https://doi.org/10.3390/antiox10121861

AMA Style

Matsuyama M, Nonaka M, Nakajima M, Morishima Y, Ishii Y, Hizawa N. The Role of NRF2 in Mycobacterial Infection. Antioxidants. 2021; 10(12):1861. https://doi.org/10.3390/antiox10121861

Chicago/Turabian Style

Matsuyama, Masashi, Mizu Nonaka, Masayuki Nakajima, Yuko Morishima, Yukio Ishii, and Nobuyuki Hizawa. 2021. "The Role of NRF2 in Mycobacterial Infection" Antioxidants 10, no. 12: 1861. https://doi.org/10.3390/antiox10121861

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop